Liver–Heart on chip models for drug safety
Open accessThe DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
Current pre-clinical models to evaluate drug safety during the drug development process (DDP) mainly rely on traditional two-dimensional cell cultures, considered too simplistic and often ineffective, or animal experimentations, which are costly, time-consuming, and not truly representative of human responses. Their clinical translation thus remains limited, eventually causing attrition and leading to high rates of failure during clinical trials. These drawbacks can be overcome by the recently developed Organs-on-Chip (OoC) technology. OoC are sophisticated in vitro systems capable of recapitulating pivotal architecture and functionalities of human organs. OoC are receiving increasing attention from the stakeholders of the DDP, particularly concerning drug screening and safety applications. When a drug is administered in the human body, it is metabolized by the liver and the resulting compound may cause unpredicted toxicity on off-target organs such as the heart. In this sense, several liver and heart models have been widely adopted to assess the toxicity of new or recalled drugs. Recent advances in OoC technology are making available platforms encompassing multiple organs fluidically connected to efficiently assess and predict the systemic effects of compounds. Such Multi-Organs-on-Chip (MOoC) platforms represent a disruptive solution to study drug-related effects, which results particularly useful to predict liver metabolism on off-target organs to ultimately improve drug safety testing in the pre-clinical phases of the DDP. In this review, we focus on recently developed liver and heart on chip systems for drug toxicity testing. In addition, MOoC platforms encompassing connected liver and heart tissues have been further reviewed and discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Emerging technologies, such as “organs-on-chips,” offer a dynamic and physiologically relevant platform for safety evaluations. These microfluidic devices mimic the functions of specific organs, enabling the study of systemic effects and interactions of cosmetic ingredients (142).”
From The dark side of beauty: an in-depth analysis of the health hazards and toxicological impact of synthetic cosmetics and personal care products (2024) · cites this paper as [142]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305
Principles of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells
Si-Tayeb, K., Noto, F. K., Nagaoka, M., Li, J., Battle, M. A., Duris, C., North, P. E., Dalton, S., & Duncan, S. A. (2010) · Hepatology · doi:10.1002/hep.23354 · Cited by 1,282
Advanced maturation of human cardiac tissue grown from pluripotent stem cells
Ronaldson-Bouchard, K., Ma, S. P., Yeager, K., Chen, T., Song, L., Sirabella, D., Morikawa, K., Teles, D., Yazawa, M., & Vunjak-Novakovic, G. (2018) · Nature · doi:10.1038/s41586-018-0016-3 · Cited by 1,272
Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip
Zhang, Y. S., Arneri, A., Bersini, S., Shin, S.-R., Zhu, K., Goli-Malekabadi, Z., Aleman, J., Colosi, C., Busignani, F., Dell'Erba, V., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.09.003 · Cited by 951
Self-citationInstrumented cardiac microphysiological devices via multimaterial three-dimensional printing
Lind, J. U., Busbee, T. A., Valentine, A. D., Pasqualini, F. S., Yuan, H., Yadid, M., Park, S.-J., Kotikian, A., Nesmith, A. P., Campbell, P. H., et al. (2017) · Nature Materials · doi:10.1038/nmat4782 · Cited by 863
Zhang, Y. S., Aleman, J., Shin, S. R., Kilic, T., Kim, D., Mousavi Shaegh, S. A., Massa, S., Riahi, R., Chae, S., Hu, N., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612906114 · Cited by 833
Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
Herrmann, J. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0348-1 · Cited by 747
Seyhan, A. A. (2019) · Translational Medicine Communications · doi:10.1186/s41231-019-0050-7 · Cited by 713
Almazroo, O. A., Miah, M. K., & Venkataramanan, R. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.08.001 · Cited by 681
Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development
Ronaldson-Bouchard, K., & Vunjak-Novakovic, G. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.02.011 · Cited by 657
Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform
Skardal, A., Murphy, S. V., Devarasetty, M., Mead, I., Kang, H.-W., Seol, Y.-J., Shrike Zhang, Y., Shin, S.-R., Zhao, L., Aleman, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08879-x · Cited by 623
A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling
Zhao, Y., Rafatian, N., Feric, N. T., Cox, B. J., Aschar-Sobbi, R., Wang, E. Y., Aggarwal, P., Zhang, B., Conant, G., Ronaldson-Bouchard, K., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.042 · Cited by 610
Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling
Skardal, A., Shupe, T., & Atala, A. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.07.003 · Cited by 512
Reproducing human and cross-species drug toxicities using a liver-chip
Jang, K.-J., Otieno, M. A., Ronxhi, J., Lim, H.-K., Ewart, L., Kodella, K. R., Petropolis, D. B., Kulkarni, G., Rubins, J. E., Conegliano, D., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aax5516 · Cited by 511
Touboul, T., Hannan, N. R. F., Corbineau, S., Martinez, A., Martinet, C., Branchereau, S., Mainot, S., Strick-Marchand, H., Pedersen, R., Di Santo, J., et al. (2010) · Hepatology · doi:10.1002/hep.23506 · Cited by 504
Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis.
Arola, O., Saraste, A., Pulkki, K. J., Kallajoki, M. A., Parvinen, M., & Voipio-Pulkki, L. M. (2000) · PubMed · Cited by 494
Oudit, G. Y., Sun, H., Trivieri, M. G., Koch, S. E., Dawood, F., Ackerley, C., Yazdanpanah, M., Wilson, G. J., Schwartz, A., Liu, P. P., et al. (2003) · Nature Medicine · doi:10.1038/nm920 · Cited by 480
Yonkers, K. A., Wisner, K. L., Stewart, D. E., Oberlander, T. F., Dell, D. L., Stotland, N., Ramin, S., Chaudron, L., & Lockwood, C. (2009) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2009.04.003 · Cited by 469
Animal models in translational medicine: Validation and prediction
Denayer, T., Stöhr, T., & Roy, M. V. (2014) · European Journal of Molecular & Clinical Medicine · doi:10.1016/j.nhtm.2014.08.001 · Cited by 448
Marsano, A., Conficconi, C., Lemme, M., Occhetta, P., Gaudiello, E., Votta, E., Cerino, G., Redaelli, A., & Rasponi, M. (2016) · Lab on a Chip · doi:10.1039/c5lc01356a · Cited by 447
Self-citationMulti-Organ toxicity demonstration in a functional human in vitro system composed of four organs
Oleaga, C., Bernabini, C., Smith, A. S. T., Srinivasan, B., Jackson, M., McLamb, W., Platt, V., Bridges, R., Cai, Y., Santhanam, N., et al. (2016) · Scientific Reports · doi:10.1038/srep20030 · Cited by 442
Organ/body-on-a-chip based on microfluidic technology for drug discovery
Kimura, H., Sakai, Y., & Fujii, T. (2018) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2017.11.003 · Cited by 435
Boudou, T., Legant, W. R., Mu, A., Borochin, M. A., Thavandiran, N., Radisic, M., Zandstra, P. W., Epstein, J. A., Margulies, K. B., & Chen, C. S. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0341 · Cited by 413
Molecular mechanisms underlying chemical liver injury
Gu, X., & Manautou, J. E. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002110 · Cited by 381
Organotypic liver culture models: meeting current challenges in toxicity testing
LeCluyse, E. L., Witek, R. P., Andersen, M. E., & Powers, M. J. (2012) · Critical Reviews in Toxicology · doi:10.3109/10408444.2012.682115 · Cited by 363
Bavli, D., Prill, S., Ezra, E., Levy, G., Cohen, M., Vinken, M., Vanfleteren, J., Jaeger, M., & Nahmias, Y. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522556113 · Cited by 362
Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol.
Olson, R. D., Mushlin, P. S., Brenner, D. E., Fleischer, S., Cusack, B. J., Chang, B. K., & Boucek, R. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.10.3585 · Cited by 357
Baxter, M., Withey, S., Harrison, S., Segeritz, C.-P., Zhang, F., Atkinson-Dell, R., Rowe, C., Gerrard, D. T., Sison-Young, R., Jenkins, R., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.016 · Cited by 348
Organ-on-a chip systems: microengineering to biomimic living systems
Zheng, F., Fu, F., Cheng, Y., Wang, C., Zhao, Y., & Gu, Z. (2016) · Small · doi:10.1002/smll.201503208 · Cited by 338
Acetaminophen hepatotoxicity: an updated review
Lancaster, E. M., Hiatt, J. R., & Zarrinpar, A. (2015) · Archives of Toxicology · doi:10.1007/s00204-014-1432-2 · Cited by 336
Cisapride and Fatal Arrhythmia
Wysowski, D. K., & Bacsanyi, J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607253350416 · Cited by 331
Elaut, G., Henkens, T., Papeleu, P., Snykers, S., Vinken, M., Vanhaecke, T., & Rogiers, V. (2006) · Current Drug Metabolism · doi:10.2174/138920006778017759 · Cited by 292
The future of drug safety testing: expanding the view and narrowing the focus
Stevens, J. L., & Baker, T. K. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.11.009 · Cited by 286
Personalised organs-on-chips: functional testing for precision medicine
van den Berg, A., Mummery, C. L., Passier, R., & van der Meer, A. D. (2019) · Lab on a Chip · doi:10.1039/c8lc00827b · Cited by 270
Drug compound screening in single and integrated multi-organoid body-on-a-chip systems
Skardal, A., Aleman, J., Forsythe, S., Rajan, S., Murphy, S., Devarasetty, M., Pourhabibi Zarandi, N., Nzou, G., Wicks, R., Sadri-Ardekani, H., et al. (2020) · Biofabrication · doi:10.1088/1758-5090/ab6d36 · Cited by 270
Maoz, B. M., Herland, A., Henry, O. Y. F., Leineweber, W. D., Yadid, M., Doyle, J., Mannix, R., Kujala, V. J., FitzGerald, E. A., Parker, K. K., et al. (2017) · Lab on a Chip · doi:10.1039/c7lc00412e · Cited by 266
Choi, S. M., Kim, Y., Shim, J. S., Park, J. T., Wang, R.-H., Leach, S. D., Liu, J. O., Deng, C., Ye, Z., & Jang, Y.-Y. (2013) · Hepatology · doi:10.1002/hep.26237 · Cited by 248
Animal models for liver disease – A practical approach for translational research
Nevzorova, Y. A., Boyer-Diaz, Z., Cubero, F. J., & Gracia-Sancho, J. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.011 · Cited by 241
Wysowski, D. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02490-x · Cited by 240
Cell sources for in vitro human liver cell culture models
Zeilinger, K., Freyer, N., Damm, G., Seehofer, D., & Knöspel, F. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216657448 · Cited by 230
Miniaturized iPS-Cell-Derived Cardiac Muscles for Physiologically Relevant Drug Response Analyses
Huebsch, N., Loskill, P., Deveshwar, N., Spencer, C. I., Judge, L. M., Mandegar, M. A., B. Fox, C., Mohamed, T. M. A., Ma, Z., Mathur, A., et al. (2016) · Scientific Reports · doi:10.1038/srep24726 · Cited by 229
A human liver microphysiology platform for investigating physiology, drug safety, and disease models
Vernetti, L. A., Senutovitch, N., Boltz, R., DeBiasio, R., Ying Shun, T., Gough, A., & Taylor, D. L. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370215592121 · Cited by 226
Detoxification pathways in the liver
Grant, D. M. (1991) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01797915 · Cited by 219
Kidambi, S., Yarmush, R. S., Novik, E., Chao, P., Yarmush, M. L., & Nahmias, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906820106 · Cited by 213
Ferri, N., Siegl, P., Corsini, A., Herrmann, J., Lerman, A., & Benghozi, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.03.005 · Cited by 205
Microfluidic Organ‐on‐a‐Chip Technology for Advancement of Drug Development and Toxicology
Caplin, J. D., Granados, N. G., James, M. R., Montazami, R., & Hashemi, N. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500040 · Cited by 205
Microfluidic titer plate for stratified 3D cell culture
Trietsch, S. J., Israëls, G. D., Joore, J., Hankemeier, T., & Vulto, P. (2013) · Lab on a Chip · doi:10.1039/c3lc50210d · Cited by 189
Predicting drug‐induced QT prolongation and torsades de pointes
Roden, D. M. (2016) · The Journal of Physiology · doi:10.1113/jp270526 · Cited by 187
Opioids and Cardiac Arrhythmia: A Literature Review
Behzadi, M., Joukar, S., & Beik, A. (2018) · Medical Principles and Practice · doi:10.1159/000492616 · Cited by 182
Shin, S. R., Kilic, T., Zhang, Y. S., Avci, H., Hu, N., Kim, D., Branco, C., Aleman, J., Massa, S., Silvestri, A., et al. (2017) · Advanced Science · doi:10.1002/advs.201600522 · Cited by 176
Oleaga, C., Riu, A., Rothemund, S., Lavado, A., McAleer, C. W., Long, C. J., Persaud, K., Narasimhan, N. S., Tran, M., Roles, J., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.062 · Cited by 175
Multi-cellular 3D human primary liver cell culture elevates metabolic activity under fluidic flow
Esch, M. B., Prot, J.-M., Wang, Y. I., Miller, P., Llamas-Vidales, J. R., Naughton, B. A., Applegate, D. R., & Shuler, M. L. (2015) · Lab on a Chip · doi:10.1039/c5lc00237k · Cited by 173
Riahi, R., Shaegh, S. A. M., Ghaderi, M., Zhang, Y. S., Shin, S. R., Aleman, J., Massa, S., Kim, D., Dokmeci, M. R., & Khademhosseini, A. (2016) · Scientific Reports · doi:10.1038/srep24598 · Cited by 172
Ferrari, E., Palma, C., Vesentini, S., Occhetta, P., & Rasponi, M. (2020) · Biosensors · doi:10.3390/bios10090110 · Cited by 172
Self-citationHigh-throughput organ-on-a-chip systems: Current status and remaining challenges
Probst, C., Schneider, S., & Loskill, P. (2018) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2018.02.004 · Cited by 171
3D Cardiac Cell Culture: A Critical Review of Current Technologies and Applications
Zuppinger, C. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00087 · Cited by 171
Impact of organ-on-a-chip technology on pharmaceutical R&D costs
Franzen, N., van Harten, W. H., Retèl, V. P., Loskill, P., van den Eijnden-van Raaij, J., & IJzerman, M. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.06.003 · Cited by 165
Bioprinted 3D vascularized tissue model for drug toxicity analysis
Massa, S., Sakr, M. A., Seo, J., Bandaru, P., Arneri, A., Bersini, S., Zare-Eelanjegh, E., Jalilian, E., Cha, B.-H., Antona, S., et al. (2017) · Biomicrofluidics · doi:10.1063/1.4994708 · Cited by 158
Ma, C., Zhao, L., Zhou, E.-M., Xu, J., Shen, S., & Wang, J. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b03869 · Cited by 145
HiPSC-derived multi-organoids-on-chip system for safety assessment of antidepressant drugs
Yin, F., Zhang, X., Wang, L., Wang, Y., Zhu, Y., Li, Z., Tao, T., Chen, W., Yu, H., & Qin, J. (2021) · Lab on a Chip · doi:10.1039/d0lc00921k · Cited by 139
Shirure, V. S., & George, S. C. (2017) · Lab on a Chip · doi:10.1039/c6lc01401a · Cited by 135
Multi-Organs-on-Chips: Towards Long-Term Biomedical Investigations
Zhao, Y., Kankala, R. K., Wang, S.-B., & Chen, A.-Z. (2019) · Molecules · doi:10.3390/molecules24040675 · Cited by 134
Simultaneous electrical recording of cardiac electrophysiology and contraction on chip
Qian, F., Huang, C., Lin, Y.-D., Ivanovskaya, A. N., O'Hara, T. J., Booth, R. H., Creek, C. J., Enright, H. A., Soscia, D. A., Belle, A. M., et al. (2017) · Lab on a Chip · doi:10.1039/c7lc00210f · Cited by 128
Sidorov, V. Y., Samson, P. C., Sidorova, T. N., Davidson, J. M., Lim, C. C., & Wikswo, J. P. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.11.009 · Cited by 127
Organ‐on‐a‐Chip Technology for Reproducing Multiorgan Physiology
Lee, S. H., & Sung, J. H. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700419 · Cited by 127
A 5-HT4-like receptor in human right atrium
Kaumann, A. J., Sanders, L., Brown, A. M., Murray, K. J., & Brown, M. J. (1991) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00167212 · Cited by 113
Integrated heart/cancer on a chip to reproduce the side effects of anti-cancer drugs in vitro
Kamei, K.-I., Kato, Y., Hirai, Y., Ito, S., Satoh, J., Oka, A., Tsuchiya, T., Chen, Y., & Tabata, O. (2017) · RSC Advances · doi:10.1039/c7ra07716e · Cited by 113
Chramiec, A., Teles, D., Yeager, K., Marturano-Kruik, A., Pak, J., Chen, T., Hao, L., Wang, M., Lock, R., Tavakol, D. N., et al. (2020) · Lab on a Chip · doi:10.1039/d0lc00424c · Cited by 113
Organs-on-a-chip: Current applications and consideration points for in vitro ADME-Tox studies
Ishida, S. (2018) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2018.01.003 · Cited by 106
Harding, S. E. (1992) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(92)91843-t · Cited by 105
Ware, B. R., Durham, M. J., Monckton, C. P., & Khetani, S. R. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.11.007 · Cited by 103
de Mello, C. P. P., Carmona‐Moran, C. A., McAleer, C. W., Perez, J., Coln, E. A., Long, C. J., Oleaga, C., Riu, A., Note, R., Teissier, S., et al. (2020) · Lab on a Chip · doi:10.1039/c9lc00861f · Cited by 100
InVADE: integrated vasculature for assessing dynamic events
Lai, B. F. L., Huyer, L. D., Lu, R. X. Z., Drecun, S., Radisic, M., & Zhang, B. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201703524 · Cited by 97
McAleer, C. W., Pointon, A., Long, C. J., Brighton, R. L., Wilkin, B. D., Bridges, L. R., Narasimhan Sriram, N., Fabre, K., McDougall, R., Muse, V. P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45656-4 · Cited by 96
Zhang, F., Qu, K.-Y., Zhou, B., Luo, Y., Zhu, Z., Pan, D., Cui, C., Zhu, Y., Chen, M., & Huang, N. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113080 · Cited by 96
On-chip three-dimensional cell culture in phaseguides improves hepatocyte functions in vitro
Jang, M., Neuzil, P., Volk, T., Manz, A., & Kleber, A. (2015) · Biomicrofluidics · doi:10.1063/1.4922863 · Cited by 95
Braña, I., & Tabernero, J. M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq295 · Cited by 93
Laminar ventricular myocardium on a microelectrode array-based chip
Kujala, V. J., Pasqualini, F. S., Goss, J. A., Nawroth, J. C., & Parker, K. K. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb00324a · Cited by 91
Engineered Liver Platforms for Different Phases of Drug Development
Ware, B. R., & Khetani, S. R. (2017) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.08.001 · Cited by 90
Integration Concepts for Multi-Organ Chips: How to Maintain Flexibility?!
Rogal, J., Probst, C., & Loskill, P. (2017) · Future Science OA · doi:10.4155/fsoa-2016-0092 · Cited by 86
Rotenone-induced oxidative stress and apoptosis in human liver HepG2 cells
Siddiqui, M. A., Ahmad, J., Farshori, N. N., Saquib, Q., Jahan, S., Kashyap, M. P., Ahamed, M., Musarrat, J., & Al-Khedhairy, A. A. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1781-9 · Cited by 84
Weng, K.-C., Kurokawa, Y. K., Hajek, B. S., Paladin, J. A., Shirure, V. S., & George, S. C. (2020) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2019.0248 · Cited by 80
Scaffold‐Free Liver‐On‐A‐Chip with Multiscale Organotypic Cultures
Weng, Y., Chang, S., Shih, M., Tseng, S., & Lai, C. (2017) · Advanced Materials · doi:10.1002/adma.201701545 · Cited by 79
Use of In Vivo Animal Models to Assess Pharmacokinetic Drug-Drug Interactions
Tang, C., & Prueksaritanont, T. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0157-z · Cited by 77
High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model
Conant, G., Lai, B. F. L., Lu, R. X. Z., Korolj, A., Wang, E. Y., & Radisic, M. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9736-2 · Cited by 75
Deng, J., Zhang, X., Chen, Z., Luo, Y., Lu, Y., Liu, T., Wu, Z., Jin, Y., Zhao, W., & Lin, B. (2019) · Biomicrofluidics · doi:10.1063/1.5070088 · Cited by 70
Long‐Term Electrical and Mechanical Function Monitoring of a Human‐on‐a‐Chip System
Oleaga, C., Lavado, A., Riu, A., Rothemund, S., Carmona‐Moran, C. A., Persaud, K., Yurko, A., Lear, J., Narasimhan, N. S., Long, C. J., et al. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201805792 · Cited by 63
A phenotypic in vitro model for the main determinants of human whole heart function
Stancescu, M., Molnar, P., McAleer, C. W., McLamb, W., Long, C. J., Oleaga, C., Prot, J.-M., & Hickman, J. J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.04.035 · Cited by 61
Visone, R., Talò, G., Occhetta, P., Cruz-Moreira, D., Lopa, S., Pappalardo, O. A., Redaelli, A., Moretti, M., & Rasponi, M. (2018) · APL Bioengineering · doi:10.1063/1.5037968 · Cited by 60
Self-citationSelf-contained, low-cost Body-on-a-Chip systems for drug development
Wang, Y. I., Oleaga, C., Long, C. J., Esch, M. B., McAleer, C. W., Miller, P. G., Hickman, J. J., & Shuler, M. L. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217694101 · Cited by 59
Zhang, X., Wang, T., Wang, P., & Hu, N. (2016) · Micromachines · doi:10.3390/mi7070122 · Cited by 58
Mitochondrial dysfunction and delayed hepatotoxicity: another lesson from troglitazone
Julie, N. L., Julie, I. M., Kende, A. I., & Wilson, G. L. (2008) · Diabetologia · doi:10.1007/s00125-008-1133-6 · Cited by 57
Truitt, R., Mu, A., Corbin, E. A., Vite, A., Brandimarto, J., Ky, B., & Margulies, K. B. (2018) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2017.12.007 · Cited by 56
Lee-Montiel, F. T., Laemmle, A., Charwat, V., Dumont, L., Lee, C. S., Huebsch, N., Okochi, H., Hancock, M. J., Siemons, B., Boggess, S. C., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.667010 · Cited by 54
Recent advances in targeted therapy for Ewing sarcoma
Pishas, K. I., & Lessnick, S. L. (2016) · F1000Research · doi:10.12688/f1000research.8631.1 · Cited by 52
Ortega‐Ribera, M., Fernández‐Iglesias, A., Illa, X., Moya, A., Molina, V., Maeso‐Díaz, R., Fondevila, C., Peralta, C., Bosch, J., Villa, R., et al. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26776 · Cited by 51
Yang, X., & Papoian, T. (2018) · Journal of Applied Toxicology · doi:10.1002/jat.3611 · Cited by 48
Visone, R., Ugolini, G. S., Cruz‐Moreira, D., Marzorati, S., Piazza, S., Pesenti, E. A., Redaelli, A. C. L., Moretti, M., Occhetta, P., & Rasponi, M. (2021) · Biofabrication · doi:10.1088/1758-5090/abe4c4 · Cited by 44
Self-citationVariability of glutathione S-transferase alpha in human liver and plasma.
MULDER, T. P. J., Court, D. A., & Peters, W. H. M. (1999) · PubMed · Cited by 43
Heart‐on‐a‐Chip Platform for Assessing Toxicity of Air Pollution Related Nanoparticles
Lu, R. X. Z., Lai, B. F. L., Benge, T., Wang, E. Y., Huyer, L. D., Rafatian, N., & Radisic, M. (2020) · Advanced Materials Technologies · doi:10.1002/admt.202000726 · Cited by 43
Microtechnology-Based Multi-Organ Models
Lee, S., & Sung, J. (2017) · Bioengineering · doi:10.3390/bioengineering4020046 · Cited by 42
Recent advances in an organ-on-a-chip: biomarker analysis and applications
Li, X., & Tian, T. (2018) · Analytical Methods · doi:10.1039/c8ay00970h · Cited by 38
Microphysiological flux balance platform unravels the dynamics of drug induced steatosis
Ehrlich, A., Tsytkin-Kirschenzweig, S., Ioannidis, K., Ayyash, M., Riu, A., Note, R., Ouedraogo, G., Vanfleteren, J., Cohen, M., & Nahmias, Y. (2018) · Lab on a Chip · doi:10.1039/c8lc00357b · Cited by 38
Variability of Glutathione S-Transferase α in Human Liver and Plasma
MULDER, T. P. J., Court, D. A., & Peters, W. H. M. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.3.355 · Cited by 37
Clomipramine concentration and withdrawal symptoms in 10 neonates
ter Horst, P. G. J., van der Linde, S., Smit, J. P., den Boon, J., van Lingen, R. A., Jansman, F. G. A., De Jong‐van den Berg, L. T. W., & Wilffert, B. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04072.x · Cited by 29
Oleaga, C., Lavado, A., Riu, A., Rothemund, S., Carmona‐Moran, C. A., Persaud, K., Yurko, A., Lear, J., Narasimhan, N. S., Long, C. J., et al. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201970049 · Cited by 27
Microfabricated Physiological Models for In Vitro Drug Screening Applications
Ugolini, G. S., Cruz‐Moreira, D., Visone, R., Redaelli, A. C. L., & Rasponi, M. (2016) · Micromachines · doi:10.3390/mi7120233 · Cited by 25
Self-citationDrug-mediated toxicity: illuminating the ‘bad’ in the test tube by means of cellular assays?
Tralau, T., & Luch, A. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.015 · Cited by 24
Microfabrication of liver and heart tissues for drug development
Brown, G. E., & Khetani, S. R. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2017.0225 · Cited by 19
Comparative haemodynamic effects of dobutamine and isoproterenol in man
Rigaud, M., Boschat, J., Rocha, P., Ferreira, A., Bardet, J., & Bourdarias, J. P. (1977) · Intensive Care Medicine · doi:10.1007/bf01683062 · Cited by 18
Gutierrez, M. M., Nicolas, L. B., Donazzolo, Y., & Dingemanse, J. (2013) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cp201806 · Cited by 15
Aronson, J. K. (1993) · PubMed · Cited by 12
Lee-Montiel, F. T., Laemmle, A., Dumont, L., Lee, C. S., Huebsch, N., Charwat, V., Okochi, H., HANCOCK, M. J., Siemons, B. A., Boggess, S. C., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.24.112771 · Cited by 11
Meyer, D. J. (2009) · Elsevier eBooks · doi:10.1016/b978-141604985-2.50014-1 · Cited by 5
(2010) · Hepatology · doi:10.1002/hep.23526 · Cited by 3
Research works printed but not linked: 3
- D. J. Meyer, “ The Liver,” in Canine Feline Cytology (Elsevier, 2010), Vol. 27, pp. 226– 248.
- 2016, Multi-organ toxicity demonstration in a functional human in vitro system composed of four organs, Sci. Rep., 6, 20030, 10.1002/adfm.201805792 · DOI · Paper page
- D. Lowe, “ The latest on drug failure and approval rates,” Sci. Transl. Med. 2, 14ps2 (2019).
Cited by
A Comprehensive Review of Organ-on-a-Chip Technology and Its Applications
Doost, N. F., & Srivastava, S. K. (2024) · Biosensors · doi:10.3390/bios14050225 · Cited by 187
Human organoids-on-chips for biomedical research and applications
Wang, H., Ning, X., Zhao, F. H., Zhao, H., & Li, D. (2024) · Theranostics · doi:10.7150/thno.90492 · Cited by 158
Emerging trends in organ-on-a-chip systems for drug screening
Wang, Y., Gao, Y., Pan, Y., Zhou, D., Liu, Y., Yin, Y., Yang, J., Wang, Y., & Song, Y. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.02.006 · Cited by 127
Advances in Spheroids and Organoids on a Chip
Fang, G., Chen, Y., Lu, H., & Jin, D. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202215043 · Cited by 141
Advances in Organ-on-a-Chip Materials and Devices
Nahak, B. K., Mishra, A., Preetam, S., & Tiwari, A. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00041 · Cited by 134
Metadata
- Authors
- Ferrari, E., & Rasponi, M.
- Affiliations
- Politecnico di Milano (IT)
- Corresponding author
- Rasponi, Marco
- Venue
- APL Bioengineering
- Publisher
- AIP Publishing
- Published
- 2021-07-14
- Volume
- 5
- Issue
- 3
- Pages
- 031505-031505
- ISSN
- 2473-2877 (ISSN-L)
- PMC
- PMC8282347
- OpenAlex
- W3180743733
- Cited by
- 53
- References
- 116
- Citations by year
- 2026: 14 · 2025: 6 · 2024: 14 · 2023: 12 · 2022: 6 · 2021: 1
- FWCI
- 0.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- APL Bioengineering (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Virtual Community of Pathological Anatomy (University of Castilla La Mancha) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Italian Ministry of Health (GR-2016-02364990)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- organ-on-a-chip, liver-on-a-chip, drug safety testing, drug toxicity, drug metabolism, off-target toxicity, drug development, in vitro model, drug attrition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.